Bone Marrow Transplantation for Patients with Chronic Myeloid Leukemia
about
Chronic myeloid leukemia: reminiscences and dreamsNCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell TrExtramedullary relapse after allogeneic bone marrow transplantation for haematological malignancy.Prevention of lethal murine graft versus host disease by treatment of donor cells with L-leucyl-L-leucine methyl ester.An overview of bone marrow transplantation for chronic myeloid leukemia.Induction of high-titer IgG antibodies against multiple leukemia-associated antigens in CML patients with clinical responses to K562/GVAX immunotherapy.Clinical and biological predictors of outcome following relapse of CML post-allo-SCTComparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation.Changing trends of chronic myeloid leukemia in greater Mumbai, India over a period of 30 years.Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplantation for chronic myeloid leukemia: an attempt to define patients who may not require further therapyHigh PR3 or ELA2 expression by CD34+ cells in advanced-phase chronic myeloid leukemia is associated with improved outcome following allogeneic stem cell transplantation and may improve PR1 peptide-driven graft-versus-leukemia effects.Bone marrow transplantation and the lung.Cellularly defined minor histocompatibility antigens are differentially expressed on human hematopoietic progenitor cells.Allogeneic and autologous bone-marrow transplantation.Emerging stem cell concepts for imatinib-resistant chronic myeloid leukaemia: implications for the biology, management, and therapy of the disease.Gender and ethnic differences in chronic myelogenous leukemia prognosis and treatment response: a single-institution retrospective studyMolecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction.The role of hematopoietic stem cell transplantation in chronic myeloid leukemia.Diagnosis and Treatment of Chronic Myeloid Leukemia in 2015.Management of the Chronic Leukemias: Special Considerations in the Elderly Patient. Part II: Chronic Granulocytic Leukemia.Current Treatment of Chronic Myeloid Leukemia.Adoptive immunotransfer with viable donor mononuclear cells for recurrent chronic myelogenous leukemia after allogeneic bone marrow transplantation in two children.Bone marrow transplantation for leukaemia.Modern management of chronic myelogenous leukemia (CML).Prospects for cure in leukaemia.Chronic myeloid leukemia: management of relapse after allogeneic bone marrow transplantation.Value of PCR analysis for long term survivors after allogeneic bone marrow transplant for chronic myelogenous leukemia: a comparative study.Long-term persistence of molecular response after discontinuation of interferon-alpha in two patients with chronic myeloid leukaemia.Imatinib-resistant chronic myeloid leukemia (CML): Current concepts on pathogenesis and new emerging pharmacologic approaches.Unrelated donor cord blood transplantation in adults with chronic myelogenous leukemia: results in nine patients from a single institution.The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia.Fate of chronic myeloid leukemia patients treated with allogeneic bone marrow transplantation or chemotherapy and/or interferon at a single center: long-term results.Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML.BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning.Fractionated total body irradiation and high dose cyclophosphamide: a preparative regimen for bone marrow transplantation for patients with hematologic malignancies in first complete remission.Common genomic HLA haplotypes contributing to successful donor search in unrelated hematopoietic transplantation.Importance of mixed chimerism to predict relapse in persistently BCR/ABL positive long survivors after allogeneic bone marrow transplantation for chronic myeloid leukemia.The story of chronic myeloid leukaemia.Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemia.Chronic Myeloid Leukemia Relapsing 25 Years after Allogenic Stem Cell Transplantation
P2860
Q26748769-1D1512B2-5AAD-4E00-94F0-BC9BEA7668B3Q34044024-9CE636C1-FF5A-47F0-B968-4726DC7BCF1AQ34095114-4672370A-90D4-4992-BBC4-09B38B3A2071Q34547736-A6504E13-9AA7-494E-A3AD-8641FFB6AEB1Q34578288-542A3354-CFA5-4F1D-B897-A9E9F52135F1Q34980976-93EFB692-660E-4DD1-817A-E2FC722F51CCQ35054717-9C3418FC-9D64-4587-AD3E-66A9499C3E9AQ35085078-2C472774-ED27-4B9D-B270-30296DFCB8C4Q35610886-436F0F52-88E4-4788-96CF-146DC508F109Q35848323-9C89661C-9883-46FC-A565-0DC41C239731Q35900929-43A5D0C9-2CA4-4DA8-A524-584C48BDF236Q36156348-C8683508-E472-494E-8AE9-0E425EC3C113Q36355711-D7F1EE97-BAA7-4A5A-8F7E-08F016FCCAE9Q36415109-1BE5F35C-2611-467F-BF85-81B64D312162Q37186806-67CFCBA6-D5DE-4D8D-A523-73FA5CF94043Q37306890-095EA0D5-ADC8-4522-903B-0474D3E9F68FQ37671841-A482CA6B-B6BA-4013-A2A7-C8770619B002Q38392690-72148FA3-D1DB-49CB-BBC6-CC83F4CFDEC8Q38598820-F482A58C-DF64-4909-8EAF-3D7BBFA10DF9Q38894184-512B2AF1-89C4-4289-AD69-F93048EB56F6Q38897680-7EB2786F-7DF9-4827-8179-D16D865C314EQ39378200-32E3F385-EEC3-4677-9C5A-552D4A90DA9FQ39520880-32F4AF86-9DC9-41FE-8686-D58BD9093BC9Q39573236-9E077168-04F7-42EC-83F0-503A86356956Q39674385-C3EFB075-A1F9-4B2C-B2C3-3D9F0D81C5CDQ40771431-5C1294F2-00EE-43D2-AD5D-DD74C699AE8DQ40983549-0E375EA1-9154-4FF5-9F55-8FB7CB453E59Q42555137-D7844283-6332-40B3-97A8-FA3C2660E28AQ43078241-55E069D1-4BBA-4E9D-BD63-C55CAA124BEEQ43613017-4B5EB50A-0F86-4AC2-B7E0-9C820EFC017BQ43635761-8A435750-4543-491C-827C-F8C8B7EE005BQ43882642-4B4E73C0-583A-41F7-BA6B-DF643F9CC548Q44511393-781A8851-F6A4-4B22-8EDC-72753623416AQ44969257-8CBD609F-46FA-4B2A-A954-1C3C947CBD1DQ47589088-053169D2-01A5-41EB-9E8C-330A55312C8CQ48004051-2CC965B5-7D0B-4487-A994-E0E2279C3DA4Q48011084-77E51624-5388-41B7-819E-361F471B3AC2Q53515689-67DF3B3F-BC33-4830-84C7-CCEDB24AF681Q54613497-27E10207-DA23-4D3D-A373-4C04DC4A9D1FQ57821741-5320DA66-D1AA-4DAC-9B5D-9E5A450DFA9A
P2860
Bone Marrow Transplantation for Patients with Chronic Myeloid Leukemia
description
article
@en
im Januar 1986 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 1986
@uk
name
Bone Marrow Transplantation for Patients with Chronic Myeloid Leukemia
@en
Bone Marrow Transplantation for Patients with Chronic Myeloid Leukemia
@nl
type
label
Bone Marrow Transplantation for Patients with Chronic Myeloid Leukemia
@en
Bone Marrow Transplantation for Patients with Chronic Myeloid Leukemia
@nl
prefLabel
Bone Marrow Transplantation for Patients with Chronic Myeloid Leukemia
@en
Bone Marrow Transplantation for Patients with Chronic Myeloid Leukemia
@nl
P2093
P921
P1476
Bone Marrow Transplantation for Patients with Chronic Myeloid Leukemia
@en
P2093
Alan W.G. Goolden
Cecil D. Reid
David A.G. Galton
Edward Gordon-Smith
Geoffrey Hale
Jane F. Apperley
John M. Goldman
Lydia Jones
Richard Batchelor
P304
P356
10.1056/NEJM198601233140403
P407
P577
1986-01-23T00:00:00Z